Brief: Landos Biopharma Q2 Net Income USD -3.922 Million
09/08/2023 13:00
Aug 09 (Reuters) - Landos Biopharma Q2 operating income USD -4.439 million. * Q2 operating expenses USD 4.439 million * Q2 basic EPS USD -0.63
Recent news on Landos Biopharma
See all newsLandos Biopharma Inc expected to post a loss of 100 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Super Micro, Micron Technology, Navios Maritime
U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Brief: AbbVie To Acquire Landos Biopharma